# SemperVirens Venture Capital

> SemperVirens Venture Capital is a VC fund backing Health Care and Software. See 73 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: San Mateo, United States
- Total investments: 73
- Last investment: Jun 2026
- Lead investor: 15%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/sempervirens-venture-capital/
- Website: https://www.sempervirensvc.com/

SemperVirens Venture Capital is a VC fund in San Mateo focused on Health Care and Software. SemperVirens Venture Capital invests in technology transforming work, health, and financial wellness.

## Contacts

5 contacts available for SemperVirens Venture Capital. Shizune tracks 8 team members at SemperVirens Venture Capital. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/sempervirens?utm_source=investor_profile

## Round sizes

| Stage | Round size |
| --- | --- |
| Seed | $4M–$8M |
| Series A | $12M–$25M |
| Series B | $27M–$65M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 16 | 22% |
| Software | 8 | 11% |
| Human Resources | 8 | 11% |
| Artificial Intelligence | 7 | 10% |
| Wellness | 6 | 8% |

55 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 21 | 29% |
| Series B | 10 | 14% |
| Seed | 9 | 12% |
| Series C | 5 | 7% |
| Funding Round | 4 | 5% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| United States | 32 | 44% |
| Belgium | 1 | 1% |
| Hong Kong | 1 | 1% |
| United Kingdom | 1 | 1% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Allison Gates | General Partner | 10 | https://shizune.co/investors/profile/allison-baum |
| Caribou Honig | Partner | 5 | https://shizune.co/investors/profile/caribou-honig |
| Christy Lake | HR Venture Advisor | 0 | https://shizune.co/investors/profile/christy-lake |
| Colin Tobias | Principal | 2 | https://shizune.co/investors/profile/colin-tobias |
| Dermot J. O'Brien | Executive Advisory Board Member | 0 | https://shizune.co/investors/profile/dermot-j-obrien |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Stepful | Stepful is an online learning platform that provides training programs for entry-level healthcare careers such as medical assistant, pharmacy technician, dental assistant, and related roles. It delivers its courses through live, instructor-led virtual classes, interactive assignments, and structured exam preparation for nationally recognizedcertifications. The platform also includes in-person clinical or externship components arranged through partner healthcare providers to help students gain practical experience. Stepful supports learners with additional services such as career coaching, resume preparation, and job search assistance after certification. Overall, it is designed to help students transition into healthcare roles by combining online instruction with hands-on training and employment support. | $55M | Series C | Jun 08, 2026 |  |
| Kubera Health | Kubera Health is a healthcare technology company that develops an AI-native platform focused on financial performance management across payor-provider relationships. The company builds software that translates healthcare contracts into structured, computable rules and connects them directly to claims and payment data. Its platform providescontinuous monitoring of reimbursement activity, enabling organizations to compare expected payments against actual payments and identify variances. Kubera Health also supports contract modeling and scenario analysis to help healthcare organizations evaluate the financial impact of rate changes and policy adjustments. The system is designed to improve visibility into complex contracting arrangements by centralizing agreement terms, fee schedules, and payment logic into a unified data model. In addition, Kubera Health offers analytics and workflow tools that support negotiation, revenue integrity, and contract performance tracking across healthcare organizations. | $6.5M | Seed | May 28, 2026 |  |
| 9amHealth | 9amHealth is a virtual healthcare company focused on managing chronic cardiometabolic conditions such as diabetes, obesity, high blood pressure, and high cholesterol. The platform connects patients with licensed healthcare providers, pharmacists, nutritionists, prescription delivery services, and at-home laboratory testing through a digital caremodel. Its services include personalized treatment plans, medication management, ongoing monitoring, and remote consultations designed to support long-term condition management. The company also works with employers, health plans, and pharmacy benefit managers to provide healthcare support programs for individuals living with chronic illnesses. 9am.health’s care approach combines medical treatment, behavioral support, and digital tools to help patients access healthcare services remotely and manage their conditions more consistently. | $26M | Series B | May 12, 2026 |  |
| Take2 AI | take2 is an online marketplace platform that provides a place for job seekers to display the skills required to land a job. | $14M | Series A | Feb 11, 2026 |  |
| Midi Health | Midi Health provides virtual healthcare services focused on midlife women’s health, especially around hormonal changes such as perimenopause and menopause, through personalized care plans delivered by clinicians trained in these areas. Its services include telehealth consultations that can integrate prescription support, supplements, lifestyleguidance, and symptom-specific treatments to address issues like weight, mood, sleep, and sexual wellness. Midi Health also offers tailored support protocols that consider an individual’s health history and goals to guide ongoing care. Its platform makes care accessible online and works with insurance for coverage of visits and prescriptions. The company additionally offers targeted supplements designed to complement its clinical care approach. | $100M | Series D | Feb 03, 2026 |  |
| Trial Library | Trial Library is an oncology clinical trials company. | $10M | Series A | Dec 02, 2025 |  |
| OneImaging | Radbutter Health saves employers 60-80% on diagnostic imaging costs equating to 10% of total health benefits spending, using the largest database, price lists, and network of imaging centers on its AI-driven care navigation platform. | $31M | Series A | Oct 14, 2025 |  |
| Penguin Ai | Penguin AI uses AI to analyze health records and support care decisions, improving patient outcomes. | $25M | Series A | Sep 11, 2025 |  |
| Certify | CertifyOS is laying the critical data infrastructure making provider data easily accessible for the U.S. healthcare system. We are an API-first, UI agnostic, platform automating the end-to-end provider network management lifecycle. With integrations into 100’s of primary sources, enabling near real-time verification and credentialing forenrollment, CertifyOS is uniquely positioned to be the one-stop shop for all provider networking needs. | $40M | Series B | Jun 26, 2025 |  |
| Empathy | Empathy is a platform for families to deal with the loss of their people. Empathy combines technology and human support to provide a digital companion application built to empower bereaved families. The company's flagship offering is a multi-platform app that guides users through the emotional and practical aspects following the loss of aloved one. This includes assistance with tasks such as funeral planning, closing accounts, and managing estate affairs. Empathy's approach is designed to reduce the complexity and stress associated with these responsibilities. | $72M | Series C | May 29, 2025 |  |

10 of 73 investments shown.

## Co-investors
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund, 14 deals together
- [Google Ventures](https://shizune.co/investors/profile/google-ventures) — VC Fund, 8 deals together
- [Index Ventures](https://shizune.co/investors/profile/index-ventures) — VC Fund, 8 deals together
- [Lightspeed Venture Partners](https://shizune.co/investors/profile/lightspeed-venture-partners) — VC Fund, 8 deals together
- [Gaingels](https://shizune.co/investors/profile/gaing) — VC Fund, 7 deals together
- [Felicis](https://shizune.co/investors/profile/felicis-ventures) — VC Fund, 6 deals together

## Similar investors

### Similar industry
- [MS&AD Ventures](https://shizune.co/investors/profile/ms-ad-ventures) — VC Fund
- [Anthemis](https://shizune.co/investors/profile/anthemis-group) — VC Fund
- [Everywhere Ventures](https://shizune.co/investors/profile/everywhere-ventures) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

### Similar country
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [East Ventures](https://shizune.co/investors/profile/east-ventures) — VC Fund
- [IDG Capital](https://shizune.co/investors/profile/idg-capital-partners) — VC Fund

## Featured in investor lists
- [InsurTech Investors in Hong Kong](https://shizune.co/investors/insurtech-investors-hong-kong)
- [InsurTech VC Funds in Hong Kong](https://shizune.co/investors/insurtech-vc-funds-hong-kong)
- [InsurTech Investors in Asia](https://shizune.co/investors/insurtech-investors-asia)
- [InsurTech VC Funds in Asia](https://shizune.co/investors/insurtech-vc-funds-asia)

## FAQ

### What does SemperVirens Venture Capital invest in?

SemperVirens Venture Capital invests primarily in Health Care, Software and Human Resources startups, most often at Series A and Series B stage. Most of the 73 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is SemperVirens Venture Capital's check size?

SemperVirens Venture Capital typically joins rounds of $4M–$8M at Seed, $12M–$25M at Series A and $27M–$65M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds SemperVirens Venture Capital participates in.

### How do I contact SemperVirens Venture Capital?

Public channels for SemperVirens Venture Capital include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at SemperVirens Venture Capital?

The team at SemperVirens Venture Capital includes Allison Gates (General Partner), Caribou Honig (Partner) and Christy Lake (HR Venture Advisor), among 8 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co